Ceren Gul

Ege, Turkey

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

A six-proline stabilized trimeric spike DNA vaccine induces robust immunity and protects against SARS-CoV-2 delta challenge in K18-hACE2 transgenic mice.

A six-proline stabilized trimeric spike DNA vaccine induces robust immunity and protects against SARS-CoV-2 delta challenge in K18-hACE2 transgenic mice.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: March 04, 2026

Comparison of the Efficacy of Cell Wall Disruption Methods for Saccharomyces cerevisiae INVSc1 cells Expressing Toxoplasma gondii Recombinant ROP6 Protein.

Comparison of the Efficacy of Cell Wall Disruption Methods for Saccharomyces cerevisiae INVSc1 cells Expressing Toxoplasma gondii Recombinant ROP6 Protein.

Journal: Protein expression and purification
Published: December 25, 2025

Comparison of the efficacy of cell wall disruption methods for Saccharomyces cerevisiae INVSc1 cells expressing Toxoplasma gondii recombinant ROP6 protein.

Comparison of the efficacy of cell wall disruption methods for Saccharomyces cerevisiae INVSc1 cells expressing Toxoplasma gondii recombinant ROP6 protein.

Journal: Protein expression and purification
Published: December 25, 2025

Recombinant ROP6 protein expressed in Saccharomyces cerevisiae INVSc1 cells induced strong immune response and provided significant protection against toxoplasmosis.

Recombinant ROP6 protein expressed in Saccharomyces cerevisiae INVSc1 cells induced strong immune response and provided significant protection against toxoplasmosis.

Journal: Scientific reports
Published: February 19, 2025

An optimized ROP6 mRNA construct successfully expressed immunogenic Toxoplasma gondii ROP6 protein in cell culture.

An optimized ROP6 mRNA construct successfully expressed immunogenic Toxoplasma gondii ROP6 protein in cell culture.

Journal: Gene
Published: August 02, 2024

A novel DNA vaccine encoding the SRS13 protein administered by electroporation confers protection against chronic toxoplasmosis.

A novel DNA vaccine encoding the SRS13 protein administered by electroporation confers protection against chronic toxoplasmosis.

Journal: Vaccine
Published: February 16, 2024

Immunogenicity and protection efficacy of a COVID-19 DNA vaccine encoding spike protein with D614G mutation and optimization of large-scale DNA vaccine production.

Immunogenicity and protection efficacy of a COVID-19 DNA vaccine encoding spike protein with D614G mutation and optimization of large-scale DNA vaccine production.

Journal: Scientific reports
Published: November 21, 2023

Genetic characterization of Toxoplasma gondii strains isolated from humans living in İzmir, Türkiye.

Genetic characterization of Toxoplasma gondii strains isolated from humans living in İzmir, Türkiye.

Journal: Indian journal of medical microbiology
Published: November 17, 2023

Importance of screening severe COVID-19 patients for IFN-λ1, IL-6 and anti-S1 IgG levels.

Importance of screening severe COVID-19 patients for IFN-λ1, IL-6 and anti-S1 IgG levels.

Journal: Cytokine
Published: July 28, 2023

A preliminary study to develop a lateral flow assay using recombinant GRA1 protein for the diagnosis of toxoplasmosis in stray cats.

A preliminary study to develop a lateral flow assay using recombinant GRA1 protein for the diagnosis of toxoplasmosis in stray cats.

Journal: Comparative immunology, microbiology and infectious diseases
Published: July 16, 2023

Biotechnological Based Recombinant Protein Vaccines Developed Against Toxoplasmosis

Biotechnological Based Recombinant Protein Vaccines Developed Against Toxoplasmosis

Journal: Turkiye parazitolojii dergisi
Published: November 29, 2022

An Overview of DNA Vaccines Development Studies Against Toxoplasma gondii

An Overview of DNA Vaccines Development Studies Against Toxoplasma gondii

Journal: Turkiye parazitolojii dergisi
Published: September 12, 2022
Showing 1-12 of 15

Last Updated: 09/26/2026